WELLS FARGO & COMPANY/MN - BLACKROCK HEALTH SCIENCES TR ownership

BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 72 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BLACKROCK HEALTH SCIENCES TR
ValueSharesWeighting
Q3 2023$13,917,848
-5.6%
355,501
-2.0%
0.00%0.0%
Q2 2023$14,744,890
-9.4%
362,817
-6.7%
0.00%
-20.0%
Q1 2023$16,271,347
+0.8%
388,707
+4.9%
0.01%0.0%
Q4 2022$16,148,700
+132.8%
370,553
+107.4%
0.01%
+150.0%
Q3 2022$6,938,000
+1.6%
178,707
+11.0%
0.00%0.0%
Q2 2022$6,827,000
+9.8%
160,998
+17.9%
0.00%0.0%
Q1 2022$6,217,000
+1.9%
136,585
+8.6%
0.00%0.0%
Q4 2021$6,102,000
-2.1%
125,799
-3.8%
0.00%
+100.0%
Q3 2021$6,234,000
+2.2%
130,814
+4.0%
0.00%0.0%
Q2 2021$6,100,000
+14.4%
125,785
+9.2%
0.00%0.0%
Q1 2021$5,330,000
-5.1%
115,237
-2.3%
0.00%0.0%
Q4 2020$5,614,000
+20.5%
117,947
+8.5%
0.00%0.0%
Q3 2020$4,659,000
+43.4%
108,700
+36.5%
0.00%0.0%
Q2 2020$3,248,000
+52.0%
79,652
+34.4%
0.00%0.0%
Q1 2020$2,137,000
-15.1%
59,286
+0.1%
0.00%0.0%
Q4 2019$2,518,000
+12.9%
59,237
+1.6%
0.00%0.0%
Q3 2019$2,231,000
-8.9%
58,317
-7.4%
0.00%0.0%
Q2 2019$2,449,000
-12.9%
62,975
-10.9%
0.00%0.0%
Q1 2019$2,813,000
+28.7%
70,699
+17.9%
0.00%0.0%
Q4 2018$2,185,000
+15.4%
59,955
+34.7%
0.00%0.0%
Q3 2018$1,894,000
+29.5%
44,522
+17.5%
0.00%
Q2 2018$1,462,000
+3.8%
37,882
-5.9%
0.00%
Q1 2018$1,409,000
-9.0%
40,269
-5.1%
0.00%
Q4 2017$1,548,000
-0.4%
42,426
-0.5%
0.00%
Q3 2017$1,554,000
+24.2%
42,629
+24.8%
0.00%
Q2 2017$1,251,000
+26.7%
34,149
+19.7%
0.00%
Q1 2017$987,000
-15.3%
28,539
-22.2%
0.00%
Q4 2016$1,165,000
+7.3%
36,675
+16.0%
0.00%
Q3 2016$1,086,000
-2.3%
31,611
+1.3%
0.00%
Q2 2016$1,112,000
-3.4%
31,212
-3.9%
0.00%
Q1 2016$1,151,000
-1.0%
32,472
+9.9%
0.00%
Q4 2015$1,163,000
+11.9%
29,555
+6.9%
0.00%
Q3 2015$1,039,000
-10.2%
27,644
+2.3%
0.00%
Q2 2015$1,157,000
-52.3%
27,033
-52.1%
0.00%
Q1 2015$2,428,000
+143.0%
56,480
+141.4%
0.00%
Q4 2014$999,000
+12.6%
23,394
+1.3%
0.00%
Q3 2014$887,000
-1.6%
23,105
-5.8%
0.00%
Q2 2014$901,000
-2.0%
24,532
-1.2%
0.00%
Q1 2014$919,000
-4.0%
24,830
-8.0%
0.00%
Q4 2013$957,000
+9.0%
27,003
+0.2%
0.00%
Q3 2013$878,000
-5.7%
26,944
-10.0%
0.00%
Q2 2013$931,00029,9510.00%
Other shareholders
BLACKROCK HEALTH SCIENCES TR shareholders Q3 2023
NameSharesValueWeighting ↓
Ahrens Investment Partners LLC 74,825$3,561,0001.91%
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 40,961$1,174,0000.99%
Diversified, LLC 19,077$818,0000.70%
CORRADO ADVISORS, LLC 9,645$459,0000.35%
Rikoon Group, LLC 16,672$793,0000.22%
Eudaimonia Partners, LLC 8,240$392,0000.09%
Arete Wealth Advisors, LLC 10,658$507,0000.07%
SOA Wealth Advisors, LLC. 4,900$242,0000.07%
Financial Advantage, Inc. 833$39,0000.04%
Jacobi Capital Management LLC 4,184$199,0000.03%
View complete list of BLACKROCK HEALTH SCIENCES TR shareholders